cefixime has been researched along with Exanthema in 2 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Exanthema: Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute localized exanthematous pustulosis (ALEP), a localized variant of acute generalized exanthematous pustulosis, is characterized by pin-sized, non-follicular, sterile pustules that typically appear on the face, neck, and chest." | 6.82 | Acute localized exanthematous pustulosis because of cefixime in a child: case report and review of pediatric cases. ( Akbayrak, A; Alev Deresoy, F; Kutlu, O; Sencan, M; Yazar, C; Yildiz Seckin, H, 2022) |
| "Acute localized exanthematous pustulosis (ALEP), a localized variant of acute generalized exanthematous pustulosis, is characterized by pin-sized, non-follicular, sterile pustules that typically appear on the face, neck, and chest." | 2.82 | Acute localized exanthematous pustulosis because of cefixime in a child: case report and review of pediatric cases. ( Akbayrak, A; Alev Deresoy, F; Kutlu, O; Sencan, M; Yazar, C; Yildiz Seckin, H, 2022) |
| "Aminopenicillin-induced exanthema poses a problem in the management of infectious diseases." | 2.73 | Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin. ( Bröcker, EB; Gross, GE; Seitz, CS; Trautmann, A; Trcka, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbayrak, A | 1 |
| Yazar, C | 1 |
| Alev Deresoy, F | 1 |
| Sencan, M | 1 |
| Yildiz Seckin, H | 1 |
| Kutlu, O | 1 |
| Trcka, J | 1 |
| Seitz, CS | 1 |
| Bröcker, EB | 1 |
| Gross, GE | 1 |
| Trautmann, A | 1 |
1 review available for cefixime and Exanthema
| Article | Year |
|---|---|
Acute localized exanthematous pustulosis because of cefixime in a child: case report and review of pediatric cases.
Topics: Acute Generalized Exanthematous Pustulosis; Amoxicillin-Potassium Clavulanate Combination; Anti-Bact | 2022 |
1 trial available for cefixime and Exanthema
| Article | Year |
|---|---|
Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefixime; Cefpodoxime; Ce | 2007 |